Pharmaceutical Technology on MSN
FDA steps back from preclinical primate testing amid wider regulatory shift
New non-primate draft guidance follows the agency’s wider aim to curtail the use of animal testing in preclinical toxicology.
The U.S. Food and Drug Administration on Tuesday issued new draft guidance on reducing the use of lab monkeys in preclinical ...
The Well News on MSN
FDA Draft Guidance Places New Limits on Toxicity Tests Involving Primates
WASHINGTON - The Food and Drug Administration released a draft guidance on Tuesday significantly reducing the range of ...
It’s getting out of control. It’s distorting the doctor-patient relationship, these endless pharmaceutical ads,” Makary told ...
The Food and Drug Administration (FDA) has issued a statement, published electronically in the New England Journal of ...
The top federal vaccine official suggested, without evidence, that the COVID-19 vaccine caused deaths in ten children.
The FDA expanded its recall of imported aluminum and brass cookware after tests showed certain products can leach harmful ...
The FDA issued a letter to Incyte on November 20 indicating that the drugmaker addressed the violations contained in an Untitled Letter it received in September.
This regular publication by DLA Piper lawyers focuses on helping clients navigate the ever-changing business, legal, and regulatory landscape.
Consumption or exposure to lead is unsafe for all ages, as it can cause neurological, developmental, and health issues.
The US Food and Drug Administration’s longtime oncology chief has filed to retire from the agency just weeks after he was tapped to lead the FDA’s drug division, according to four people familiar with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback